UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055680
Receipt number R000063623
Scientific Title Development and Clinical Evaluation of a Motion Assistance Device for the Prevention of Bowlegs
Date of disclosure of the study information 2024/10/01
Last modified on 2024/09/30 18:49:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development and Clinical Evaluation of a Motion Assistance Device for the Prevention of Bowlegs

Acronym

Development and Clinical Evaluation of a Motion Assistance Device for the Prevention of Bowlegs

Scientific Title

Development and Clinical Evaluation of a Motion Assistance Device for the Prevention of Bowlegs

Scientific Title:Acronym

Development and Clinical Evaluation of a Motion Assistance Device for the Prevention of Bowlegs

Region

Japan


Condition

Condition

knee osteoarthritis

Classification by specialty

Orthopedics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Verification of the effectiveness of the developed system

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Lateral knee acceleration
Gait data

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Wear the device and walk for 10 minutes

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Patients with osteoarthritis of the knee
(ii) Post-operative osteoarthritis patients who can walk normally without the assistance of a third party
(iii) Healthy elderly people

Key exclusion criteria

1. Uncontrolled heart failure
2. Acute myocardial infarction
3. Active myocarditis or pericarditis
4. Unstable angina
5. Acute systemic embolism or pulmonary embolism
6. Acute infection
7. Thrombophlebitis
8. Ventricular tachycardia or refractory ventricular arrhythmia
9. Severe ventricular outflow tract obstruction
10. Uncontrolled arterial or pulmonary hypertension
11. Those who are not capable of performing the tasks indicated in the test procedure (including breaks between tasks)
12. If the patient is in another intervention study at the same time (verbally confirmed with the physiotherapist in charge)
*Exclusion criteria are made at the discretion of the physician in charge

Target sample size

48


Research contact person

Name of lead principal investigator

1st name Hiroyasu
Middle name
Last name Iwata

Organization

Waseda University

Division name

Faculty science and engineering

Zip code

162-0042

Address

27 Waseda-machi, Shinjuku-ku, Tokyo 162-0044, Japan Green Computing Systems Reserch Organization 603 Prof. Iwata Lab.

TEL

03-3203-4427

Email

jubi@waseda.jp


Public contact

Name of contact person

1st name Hiroyasu
Middle name
Last name Iwata

Organization

Waseda University

Division name

Faculty science and engineering

Zip code

162-0042

Address

27 Waseda-machi, Shinjuku-ku, Tokyo 162-0044, Japan Green Computing Systems Reserch Organization 603

TEL

03-3203-4427

Homepage URL


Email

jubi@waseda.jp


Sponsor or person

Institute

Waseda University

Institute

Department

Personal name



Funding Source

Organization

Waseda University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Yokohama Seishinkai Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Waseda University Ethics Review Committee

Address

Bldg. 9, 2F, 1-104 Totsukacho, Shinjuku-ku, Tokyo

Tel

03-5272-1639

Email

rinri@list.waseda.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

横浜石心会病院(神奈川県)


Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2024 Year 10 Month 01 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 09 Month 30 Day

Last modified on

2024 Year 09 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063623